Palomid 529

· Paloma Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Palomid 529, covering 2012-09-24 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration [Phase 1]